ASTELLAS PHARMA : Astellas Submits U.S. New Drug Application for ... 4-traders Astellas Submits U.S. New Drug Application for Tacrolimus Extended Release Capsules, a Prophylaxis of Organ Rejection in Transplant Recipients NORTHBROOK, IL. Sept., 24, 2012 - Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based ... |
